By Press Release / October 8, 2018
The U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell…
By Press Release / May 14, 2018
Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for…
By Press Release / March 6, 2018
SkinCeuticals unveils Glycolic 10 Renew Overnight – the latest addition to the Correct portfolio. This innovative product works at a…
By Press Release / October 10, 2016
Sun Pharma has announced late-breaking data from two pivotal Phase-3 clinical trials (reSURFACE 1 and 2) achieving the primary endpoint…
By Euromedicom / May 18, 2016
PRIME previews the 7th International Congress in Aesthetic Dermatology (ICAD 2016), taking place in Bangkok, Thailand, on 24–26 November 2016….
By Press Release / January 13, 2016
Acquisition adds global rights to novel NDS™ platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product
By Imran Majid et al. / September 15, 2014
Imran Majid and Gousia Sheikh review the use of microneedling for the treatment of acne scars and a growing number of new applications, such as transdermal drug delivery and hair restoration
By Anon. / June 23, 2014
The number of skin and soft tissue infections (SSTI) has skyrocketed owing to the spread of meticillin-resistant Staphylococcus aureus (MRSA)….
By Anon. / May 30, 2014
LightSheer® INFINITY™ is one of the most advanced solutions for laser hair removal and treats the broadest range of skin types
By Anon. / May 23, 2014
Dr Matteo Tretti Clementoni discusses his experience using lasers for the rejuvenation of the skin, and particularly the ResurFX device from Lumenis
